http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 23 Jul 2026 09:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Report+Second-Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26805518.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the second quarter of 2026 on Tuesday, August 4, 2026, following the close of the market. Management will discuss these results in a conference call scheduled for 2:00 PM Pacific Time (5:00 PM Eastern Time) that day. </p><p> To participate, dial (800) 715-9871 within the U.S. or (646) 307-1963 outside the U.S., access code: 9562470. A live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F574651705&amp;esheet=54575400&amp;newsitemid=20260723046581&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=ddef029073f0bb1d702cf0dff58ae03c" shape="rect">webcast</a> of the conference call will also be available in the http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Report+Second-Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26805518.html Thu, 23 Jul 2026 09:00:00 -0400 BIO BIO.B O.00005917 http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Report+Second-Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26805518.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the second quarter of 2026 on Tuesday, August 4, 2026, following the close of the market. Management will discuss these results in a conference call scheduled for 2:00 PM Pacific Time (5:00 PM Eastern Time) that day. </p><p> To participate, dial (800) 715-9871 within the U.S. or (646) 307-1963 outside the U.S., access code: 9562470. A live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F574651705&amp;esheet=54575400&amp;newsitemid=20260723046581&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=ddef029073f0bb1d702cf0dff58ae03c" shape="rect">webcast</a> of the conference call will also be available in the http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Report+Second-Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26805518.html Thu, 23 Jul 2026 09:00:00 -0400 BIO BIO.B O.00005917 http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Report+Second-Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26805518.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the second quarter of 2026 on Tuesday, August 4, 2026, following the close of the market. Management will discuss these results in a conference call scheduled for 2:00 PM Pacific Time (5:00 PM Eastern Time) that day. </p><p> To participate, dial (800) 715-9871 within the U.S. or (646) 307-1963 outside the U.S., access code: 9562470. A live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F574651705&amp;esheet=54575400&amp;newsitemid=20260723046581&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=ddef029073f0bb1d702cf0dff58ae03c" shape="rect">webcast</a> of the conference call will also be available in the http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Report+Second-Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26805518.html Thu, 23 Jul 2026 09:00:00 -0400 BIO BIO.B O.00005917 http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Report+Second-Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26805518.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the second quarter of 2026 on Tuesday, August 4, 2026, following the close of the market. Management will discuss these results in a conference call scheduled for 2:00 PM Pacific Time (5:00 PM Eastern Time) that day. </p><p> To participate, dial (800) 715-9871 within the U.S. or (646) 307-1963 outside the U.S., access code: 9562470. A live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F574651705&amp;esheet=54575400&amp;newsitemid=20260723046581&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=ddef029073f0bb1d702cf0dff58ae03c" shape="rect">webcast</a> of the conference call will also be available in the http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Report+Second-Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26805518.html Thu, 23 Jul 2026 09:00:00 -0400 BIO BIO.B O.00005917 http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Report+Second-Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26805518.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the second quarter of 2026 on Tuesday, August 4, 2026, following the close of the market. Management will discuss these results in a conference call scheduled for 2:00 PM Pacific Time (5:00 PM Eastern Time) that day. </p><p> To participate, dial (800) 715-9871 within the U.S. or (646) 307-1963 outside the U.S., access code: 9562470. A live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F574651705&amp;esheet=54575400&amp;newsitemid=20260723046581&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=ddef029073f0bb1d702cf0dff58ae03c" shape="rect">webcast</a> of the conference call will also be available in the http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Report+Second-Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26805518.html Thu, 23 Jul 2026 09:00:00 -0400 BIO BIO.B O.00005917 http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Report+Second-Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26805518.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the second quarter of 2026 on Tuesday, August 4, 2026, following the close of the market. Management will discuss these results in a conference call scheduled for 2:00 PM Pacific Time (5:00 PM Eastern Time) that day. </p><p> To participate, dial (800) 715-9871 within the U.S. or (646) 307-1963 outside the U.S., access code: 9562470. A live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F574651705&amp;esheet=54575400&amp;newsitemid=20260723046581&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=ddef029073f0bb1d702cf0dff58ae03c" shape="rect">webcast</a> of the conference call will also be available in the http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Report+Second-Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26805518.html Thu, 23 Jul 2026 09:00:00 -0400 BIO BIO.B O.00005917 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BIO-RAD+LABORATORIES%2C+++++For%3A+May+11++Filed+by%3A+ENGELHARDT+EVA+ANETTE/26485481.html si-local-file:///var/storage/secattach/20260513/26485481.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BIO-RAD+LABORATORIES%2C+++++For%3A+May+11++Filed+by%3A+ENGELHARDT+EVA+ANETTE/26485481.html Wed, 13 May 2026 15:38:00 -0400 BIO BIO.B O.00005917 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BIO-RAD+LABORATORIES%2C+++++For%3A+May+11++Filed+by%3A+ENGELHARDT+EVA+ANETTE/26485481.html si-local-file:///var/storage/secattach/20260513/26485481.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BIO-RAD+LABORATORIES%2C+++++For%3A+May+11++Filed+by%3A+ENGELHARDT+EVA+ANETTE/26485481.html Wed, 13 May 2026 15:38:00 -0400 BIO BIO.B O.00005917 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BIO-RAD+LABORATORIES%2C+++++For%3A+May+11++Filed+by%3A+ENGELHARDT+EVA+ANETTE/26485481.html si-local-file:///var/storage/secattach/20260513/26485481.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BIO-RAD+LABORATORIES%2C+++++For%3A+May+11++Filed+by%3A+ENGELHARDT+EVA+ANETTE/26485481.html Wed, 13 May 2026 15:38:00 -0400 BIO BIO.B O.00005917 http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637